Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin
- 28 June 2004
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 23 (39) , 6541-6547
- https://doi.org/10.1038/sj.onc.1207858
Abstract
Previously, we have mimicked human neurofibromatosis type 2 (NF2) in conditional Nf2 mutant (P0Cre;Nf2flox2/flox2) mice. Schwannomas, characteristic for NF2, were found at low frequency in older mice. Here, we report that these mice, upon additional hemizygosity for p53, rapidly develop multiple tumours showing features consistent with malignant peripheral nerve sheath tumours. Thus, p53 hemizygosity promotes tumorigenesis of mutant Nf2 peripheral nerve cells. In contrast, young P0Cre;Nf2flox2/+;p53+/− cis mice mainly succumb to Nf2/p53-related osteogenic tumours. Therefore, Cre-mediated early biallelic loss of Nf2 function in neural crest-derived cells hemizygous for p53 results in resistance to osteogenic tumours and increased susceptibility to peripheral nerve sheath tumours.Keywords
This publication has 23 references indexed in Scilit:
- Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouseGenes & Development, 2002
- The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44Genes & Development, 2001
- ERM-Merlin and EBP50 Protein Families in Plasma Membrane Organization and FunctionAnnual Review of Cell and Developmental Biology, 2000
- Mouse Models of Tumor Development in Neurofibromatosis Type 1Science, 1999
- Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitroOncogene, 1999
- The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.Genes & Development, 1997
- Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.Genes & Development, 1997
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2Nature, 1993
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992